MXD3 is a transcriptional repressor that antagonizes the activity of MYC, a well-known oncogene . By competing for MAX, MXD3 suppresses MYC-dependent cell transformation and proliferation . The protein is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis . Disruption of the MAX-MXD3 complex has been associated with uncontrolled cell proliferation and tumorigenesis .
The human recombinant form of MXD3 is produced in E. coli and is a single, non-glycosylated polypeptide chain containing 229 amino acids . It has a molecular mass of approximately 25.9 kDa and is fused to a 23 amino acid His-tag at the N-terminus . This recombinant protein is purified using proprietary chromatographic techniques to ensure high purity and functionality .
MXD3 has been implicated in various diseases, including appendix carcinoid tumors and arteriovenous malformations of the brain . Its role in the MYC-MAX-MXD network makes it a significant factor in cancer research, as it can influence the proliferation, differentiation, and apoptosis of cells . Understanding the function and regulation of MXD3 can provide insights into potential therapeutic targets for cancer treatment.